《Table 1 Studies of pharmacological therapies with immunomodulatory properties in animal models of A

《Table 1 Studies of pharmacological therapies with immunomodulatory properties in animal models of A   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's disease》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录

The pharmaceutical therapies were with fasudil,LW-AFC,curcumin,TNF inhibitor XPro1595,IL-1 receptor antagonist(IL-1RA),pioglitazone,rosiglitazone,quercetin,IL-1β,cannabidiol,multi-targeted diet(zinc,melatonin,curcumin,piperine,eicosapentaenoic acid,docosahexaenoic acid,uridine,choline),and clioquinol.These have all been shown to have immunomodulatory properties(fasudil:Thorlacius et al.,2006;Song et al.,2013;Liu et al.,2015;LW-AFC:Wang et al.,2016;curcumin:Gaulam et al.,2007;TNF inhibitor XPro1595:Fischer et al.,2015;IL-1RA:Granowitz et al.,1992;Nedumpun et al.,2017;pioglitazone:Singh et al.,2011;El-Sisi et al.,2015;rosiglitazone:Liu et al.,2009;Serghides et al.,2009;quercetin:Li et al.,2016;Casas-Grajales et al.,2017;IL-1β:Chen et al.,2010;cannabidiol:Mecha et al.,2013;Zgair et al.,2017;memantine:Lowinus et al.,2016;Lee et al.,2015;melatonin:Giannoulia-Karantana et al.,2006;Medrano-Campillo et al.,2015;piperine:Sunila and Kuttan,2004;Rodgers et al.,2009;eicosapentaenoic acid:Iwami et al.,2011;Hirahashi et al.,2014;decosahexaenoic acid:Koch et al.,2006;Hjorth and Freund-Levi,2012;uridine:Abood et al.,2014;choline:Pavlov et al.,2003;Parrish et al.,2006;Parrish et al.,2008;Rowley et al.,2010;clioquinol:Kidd et al.,2016).The thirteen animal studies utilizing these pharmaceutical agents are summarized in Table 1.Eleven of these studies had used mouse models,and two a rat model.In the mouse studies,the ages of the animals at which treatment was started ranged from 6 weeks to 21 months and where gender was specified 4 had used males,3 females,and 2 both males and females.The rat studies had used males,with ages ranging from 8 weeks to 4 months.The treatment period with the pharmacological agent ranged from 30 days to 5 months.